1/20
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
CBER
Division of FDA regulating blood, blood products, tissues, biologics
Authority from PHSA & FDCA
FDA Biologics License Application (BLA)
Required for interstate shipment of blood products
Issued by FDA/CBER
Quality Assurance (QA) vs Quality Control (QC)
QA: system-wide program ensuring compliance & quality, process-focused
QC: routine testing of reagents, equipment, procedures, product-focused
Lookback Program
Manufacturer investigates when post-donation info shows donor infection risk (e.g., HIV, HBV)
NOT the responsibility of the transfusion service to initiate manufacturer lookback
Fatality Reporting
Manufacturer must report to FDA/CBER within 7 days of awareness
Records Retention – 10 years
Donor deferrals, donor records, recipient records, donor test results
Records Retention – 5 years
Recipient testing, transfusion reaction workups, proficiency testing, QC records
Blood Utilization Management
Goals: better patient outcomes, lower healthcare costs, efficient use of blood supply
NOT about fostering respectful interactions with physicians
Patient Blood Management (PBM)
Hospital-based program to minimize inappropriate transfusion
Uses evidence-based guidelines & clinician education
Rare Antiserum QC
Test with one known antigen-positive and one antigen-negative cell
Short Supply Arrangements
Manufacturer’s responsibility, not transfusion service
Procedures to ensure supply in shortage situations
Current Good Manufacturing Practices (cGMP)
FDA-enforced standards for manufacturing, testing, and quality systems
Applies to blood collection and processing facilities
AABB
Professional organization; accreditation often required for hospital blood banks
Publishes Standards for Blood Banks and Transfusion Services
CMS (Centers for Medicare & Medicaid Services)
Enforces CLIA regulations for lab testing, including transfusion services
Joint Commission (JCAHO)
Accrediting body; evaluates hospital compliance with patient care standards, including transfusion safety
Proficiency Testing Requirement
CLIA mandates participation in approved PT programs for all regulated analytes
Inventory Monitoring
All blood bank staff are responsible for monitoring inventory levels
Shipping Blood Across State Lines
Requires FDA-approved BLA
Does NOT require AABB accreditation or CMS certification
Donor Deferral Lists
Must be maintained for permanent and temporary deferrals
Retained for at least 10 years
Transfusion Reaction Reporting
Facilities must investigate all suspected reactions
Report fatalities to FDA within required timeframe
Compliance vs Regulatory Agencies
FDA: safety & efficacy of biologics/blood
CMS: CLIA oversight of lab quality
AABB: accreditation & best practice standards
Joint Commission: hospital accreditation